About Replasia

Engineering better possibilities for hip preservation.

Replasia is a Belgian medical technology company developing patient-specific solutions for hip preservation in young adults. We combine three-dimensional anatomical analysis, kinematic simulation and treatment concepts engineered around the individual anatomy.

Young woman hiking in a sunlit forest
AI generated

Purpose

Built around the individual hip

Hip preservation decisions require a clear understanding of anatomy, movement and the individual patient’s condition. Replasia was founded to help clinical teams move from fragmented information to a quantified, patient-specific view of the native hip.

Our work begins with three-dimensional diagnosis and treatment planning through HipStudio. It extends toward patient-specific treatment concepts developed around the anatomy and the correction selected by the surgeon.

Mission

To give young adults with hip conditions the best possible chance of leading a healthy, active life.

Vision

A world where no young adult is forced into hip replacement due to a lack of diagnostic data or optimal treatment options.

Quality management

Quality built into how we work

Replasia’s quality management system is ISO 13485 certified, providing a structured framework for controlled medical-device development, risk management and traceability.

  • ISO 13485 certified quality management system
  • Independently certified by Kiwa
  • Certified since 2025

Team

A focused, multidisciplinary team

Replasia brings together experience in biomedical engineering, medical-device development, software, additive manufacturing, quality and regulatory affairs. We work closely with hip-preservation surgeons and clinical partners to translate complex anatomy into solutions that are useful in clinical practice.

Portrait of Peter Mercelis, CEO & CO-FOUNDER at Replasia

Peter Mercelis

CEO & CO-FOUNDER

Peter holds a PhD in electromechanical engineering from KU Leuven and has more than two decades of experience as a medical-device and 3D-printing entrepreneur. He co-founded and led LayerWise, a pioneer in medical 3D printing later acquired by 3D Systems, and has since supported multiple technology and healthcare ventures.

LinkedIn
Portrait of Tim Van Cleynenbreugel, CTO & CO-FOUNDER at Replasia

Tim Van Cleynenbreugel

CTO & CO-FOUNDER

Tim holds a PhD in engineering from KU Leuven and brings more than two decades of experience across medical imaging, polymer and metal additive manufacturing, and medical-device development, including management and director roles at Materialise, LayerWise and Comate.

LinkedIn
Portrait of Alexander Meynen, Project Manager at Replasia

Alexander Meynen

Project Manager

Alexander is a biomedical engineer with a PhD from KU Leuven. He has a research background in biomechanics, quantitative 3D imaging, statistical shape modelling, AI and patient-specific orthopaedic implant design.

LinkedIn